Scholars Central

ArticlePublished 30 Sep 2022

Status at discharge and efficacy of protocolized medications for covid19 in intensive care

Authors: Rafael Miranda Pedroso, Ana Iris Padrino López, Suleivis Gato Mesa, Jorge Rogelio Rodriguez Martinez

Systematic Reviews in Pharmacy

Volume 13 · Issue 9 · Pages 639–644

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: The use of certain medications in COVID-19 affects the discharge status of patients. Objective: To relate the state of discharge, with age, condition and efficacy of protocolized medications in severe and critical patients with COVID-19. Methods: An epidemiological, retrospective investigation was carried out in the intensive care unit of the provincial clinical surgical teaching hospital doctor León Cuervo Rubio, the universe and sample consisted of those admitted from March 2020 to July 2021, the variables were grouped in tables. According to affinity, the results were expressed by odds ratio, absolute risk reduction, in addition, the absolute and relative frequencies were estimated, the data were processed, using the statistical software MedCalc for Windows. Results: Most of the patients were discharged alive 88 (66.67%), mortality was similar in the age groups of 70 to 79 and 80 to 89 years 12 (9.72%), the alive ones are serious 42 (34.15%), critically unstable deceased 22(17.8%), when relating the state at discharge with medications, those who receive Jusvinza have a high probability of being discharged alive 94(OR 389.400, CI-22.3484 to 6784.9271, P<0.0001), it also reduces mortality by 70.7% (CI-17.28, 694e), with a high sensitivity of 87.23% and specificity of 100%. Conclusion: Most of the discharges are alive; the most effective medication used is Jusvinza peptide, as it increases the probability of life of patients and its positive effect on mortality.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalSystematic Reviews in Pharmacy
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Rafael Miranda Pedroso”
  • BylineArticles whose byline prints “Ana Iris Padrino López”
  • BylineArticles whose byline prints “Suleivis Gato Mesa”
  • BylineArticles whose byline prints “Jorge Rogelio Rodriguez Martinez”